A startup has raised $191 million to develop gene editing technology that makes pig organs compatible for human transplants. This initiative aims to address the critical shortage of organ donors, with over 100,000 Americans currently on transplant waiting lists. Lux Capital led the funding round, highlighting the potential for significant advancements in the field of xenotransplantation. Prior to this, a related entity, eGenesisBio, was involved in similar efforts.
Awesome to see this fundraising news. Prior to @HyperGuap, I worked at @eGenesisBio. A new supply of organs is desperately needed. 3D printing sounds cool, but xeno is much more practical in the near-term. https://t.co/b28S8F21NW
SCI-FI <> SCI-FACT We should not have to suffer relying on long organ donor transplant lists But think crazier🧠––think SCI-FI future where people monitor + upgrade their organs as regularly as they upgrade iphones🫀🫁 Lux leads $191M round👇 https://t.co/cL2H9k3hRR
Startup raises more cash to edit pig organs for human transplant https://t.co/hPIfGn6eOM